Business Description
Allarity Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US0167443029
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | -0.23 | |||||
Debt-to-Equity | -0.47 | |||||
Debt-to-EBITDA | -0.12 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 51.8 | |||||
3-Year EPS without NRI Growth Rate | 44.8 | |||||
3-Year FCF Growth Rate | 52.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 14.38 | |||||
9-Day RSI | 13.31 | |||||
14-Day RSI | 13.78 | |||||
6-1 Month Momentum % | -61.85 | |||||
12-1 Month Momentum % | -98.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.14 | |||||
Quick Ratio | 0.14 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -266.1 | |||||
Shareholder Yield % | -10.37 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -89.6 | |||||
ROIC % | -124.75 | |||||
ROC (Joel Greenblatt) % | -44566.93 | |||||
ROCE % | -5549.02 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.42 | |||||
EV-to-EBITDA | -0.43 | |||||
EV-to-FCF | -0.37 | |||||
Earnings Yield (Greenblatt) % | -238.1 | |||||
FCF Yield % | -616.89 |